Novartis India reports net loss at Rs 71 lakh in Q3
New Delhi: Drug firm Novartis India on Thursday reported a net loss of Rs 71 lakh for the quarter ended December 31, 2020.
The company had posted a net profit of Rs 7.73 crore for the corresponding period of the previous fiscal, Novartis India said in a filing to BSE.
Revenue from operations of the company stood at Rs 93.77 core for the quarter under consideration. It was Rs 117.46 crore for the same period a year ago, it added.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd